
Aecef S 250mg/125mg Injection
Marketer
Aadi Health Care
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Aecef S 250mg/125mg Injection
Cefixime and Sulbactam 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and halting infection progression. Administration must be strictly under medical guidance; consistent adherence to the prescribed schedule is vital. Complete the entire course of treatment, regardless of symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions such as rashes, itching, swelling, or breathing difficulties. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, nutritious food, and ample hydration will promote faster recovery. Your physician may order tests to monitor the medication's effects.
Uses of Aecef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Aecef S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Aecef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Aecef S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Aecef S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Aecef S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The beta-lactamase inhibitor, Sulbactam, counteracts bacterial defenses, boosting Ceftriaxone's effectiveness and overcoming resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Aecef S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Aecef S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Aecef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Aecef S 250mg/125mg can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Aecef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The administration of Aecef S 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment, potentially necessitating dosage modification. Physician consultation is advised. Dosage alteration for Aecef S 250mg/125mg Injection is generally not advised for those with mild or moderately compromised liver function.
What if you forget to take Aecef S 250mg/125mg Injection :
Omit a dose of Aecef S 250mg/125mg Injection? Seek medical advice immediately.
Facts to Know About Aecef S 250mg/125mg Injection
Label | Value |
---|---|
Addictive | None. |
Medication Category | Antimicrobial Agents |